Find policies, billing codes, payers, states, and providers
CPT 92283: Anomaloscope Color Vision Testing
CPT code 92283 identifies a specialized ophthalmic diagnostic test using an anomaloscope or similar optical instrument to assess color vision, primarily for detecting red–green color blindness. This code matters nationally as it supports clinical assessment of color perception disorders that can affect occupational fitness, driving safety, and management of ocular or neurologic conditions. Use of a specific CPT code facilitates consistent reporting, clinical documentation, and payer reimbursement for an objective instrument-based color vision evaluation.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical purpose of the test, typical sites where it is performed, and the context for billing such a service. The publication summarizes payment and coverage considerations across major national payers, clarifies clinical context for documentation, and flags areas where data are not available in the input. It also outlines what to expect in terms of coding classification and common administrative considerations for reporting this diagnostic ophthalmic service.
Customize your policy alerts
Sign up for cpt 92283 policy alerts
Get alerted when payer policies referencing 92283 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 92283 describes an eye test that uses an optical instrument, such as a Nagel anomaloscope, employing long-wavelength yellow–green light that a patient adjusts to match a predetermined red-to-green ratio. This diagnostic procedure is performed to determine color vision defects, most commonly red–green color blindness.
-
Service type: Diagnostic ophthalmic color vision testing using specialized optical instrumentation
-
Typical site of service: Outpatient ophthalmology or optometry clinic, vision testing laboratory, or ambulatory eye care setting